Economic Burden Can Be the Major Determining Factor Resulting in Short-Term Intermittent and Repetitive Ustekinumab Treatment for Moderate-to-Severe Psoriasis

BACKGROUND: The continuous use of biologic agents in the treatment of psoriasis has been reported to result in successful and sustained therapeutic effects and safety. However, some patients choose intermittent and repetitive treatment. OBJECTIVE: To determine the factors for selecting intermittent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Dermatol
Autors principals: Choi, Chong Won, Choi, Ji Young, Kim, Bo Ri, Youn, Sang Woong
Format: Artigo
Idioma:Inglês
Publicat: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5839889/
https://ncbi.nlm.nih.gov/pubmed/29606815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2018.30.2.179
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars